Official recall notice

FDA DrugClass IINotable

FDA Recall: Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distri

Recall date
2026-09-23
Brand
Pfizer
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Lack of Assurance of Sterility

Product description

Lack of Assurance of Sterility

Affected products

Lot # NL5230, Exp Date:10/2027

Verify with the official notice →
Share:

Related Recalls

2026-10-01 · FDA_DRUG
FDA Recall: Greewich: Glutathione Injection
Greewich
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 5 mg per 10 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 15 mg per 3 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 20 mg per 4 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC